|Articles|January 29, 2015
Pharma 2015: Industry in Flux
Author(s)William Looney
Pharma is still a 21st Century growth industry, but investment dynamics no longer favor organic growth. Check out our strategic outlook infographic.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Moving CAR-T Beyond Oncology
3
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
4
Navigating Complexity in Emerging Biotech: Innovations, Integrations, and Initial Hurdles
5